An association between inflammation, obesity and adiponectin biology is emerging in studies of Type 1 diabetes (T1D) and its complications, promoting the investigation of adiponectin receptor biology in models of both T1D and Type 2 diabetes (T2D). Here, ADIPOQ is linked to type 2 diabetes mellitus.